Player FM - Internet Radio Done Right
22 subscribers
Checked 2y ago
Hozzáadva kilenc éve
cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!
Player FM 앱으로 오프라인으로 전환하세요!
The Promise of Immunotherapy in Lung Cancer
Manage episode 120493211 series 98519
cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.
301 에피소드
Manage episode 120493211 series 98519
cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.
301 에피소드
Minden epizód
×G
GRACEcast Lung Cancer Video
1 Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 4:36
4:36
나중에 재생
나중에 재생
리스트
좋아요
좋아요
4:36Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.
G
GRACEcast Lung Cancer Video
1 Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 5:28
5:28
나중에 재생
나중에 재생
리스트
좋아요
좋아요
5:28The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.
G
GRACEcast Lung Cancer Video
1 Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 2:27
2:27
나중에 재생
나중에 재생
리스트
좋아요
좋아요
2:27Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
G
GRACEcast Lung Cancer Video
1 Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 7:28
7:28
나중에 재생
나중에 재생
리스트
좋아요
좋아요
7:28The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.
G
GRACEcast Lung Cancer Video
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
G
GRACEcast Lung Cancer Video
1 What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer 3:52
3:52
나중에 재생
나중에 재생
리스트
좋아요
좋아요
3:52"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
G
GRACEcast Lung Cancer Video
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.
G
GRACEcast Lung Cancer Video
1 CO1686 - 3rd Generation Drug for Acquired Resistance in EGFR Lung Cancer 4:10
4:10
나중에 재생
나중에 재생
리스트
좋아요
좋아요
4:10Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.
G
GRACEcast Lung Cancer Video
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.
G
GRACEcast Lung Cancer Video
1 AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer 11:36
11:36
나중에 재생
나중에 재생
리스트
좋아요
좋아요
11:36EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.
G
GRACEcast Lung Cancer Video
1 What Are Heat Shock Protein (HSP) 90 Inhibitors and How May They Help Fight Lung Cancer? 2:17
2:17
나중에 재생
나중에 재생
리스트
좋아요
좋아요
2:17"HSP 90 inhibitors are a really cool class of drugs..." states Dr. Melissa Johnson of the Robert H. Lurie Comprehensive Cancer Center as she describes what researchers are learning about these drugs still in early development. February 2014.
G
GRACEcast Lung Cancer Video
Dr. Leena Gandhi of Dana-Farber Cancer Institute sees great potential in immune therapies for lung cancer. In this video, she expresses her hope and excitement for what the future may hold. February 2014.
G
GRACEcast Lung Cancer Video
An analysis of two large studies of EGFR lung cancer patients tried to determine if Gilotrif helped patients live longer.
G
GRACEcast Lung Cancer Video
Progression-free survival is something that doctors measure to determine how well a patient responds to a particular treatment. But does it translate to increased overall survival?
G
GRACEcast Lung Cancer Video
A genetic mutation and a leukemia drug may provide new hope for patients with squamous cell lung cancer patients.
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.